Opevesostat (MK-5684, ODM-208) is an orally active and selective CYP11A1 inhibitor. Opevesostat has the potential for the research of metastatic castration-resistant prostate cancer (mCRPC)[1].
Molecular Weight:
418.51
Purity:
99.79
CAS Number:
[2231294-96-3]
Formula:
C21H26N2O5S
Target:
Cytochrome P450
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted